Camber Pharmaceuticals, Inc. has recalled several lots of Lacosamide Oral Solution (lacosamide), a prescription medication used to treat seizures. The recall was initiated because the product failed quality testing for the amount of p-Hydroxybenzoic Acid, an inactive ingredient used as a preservative. No injuries or adverse incidents have been reported in connection with this recall.
The level of p-Hydroxybenzoic Acid was found to be outside of the required specifications, which may affect the medication's stability and preservative effectiveness over time. This could potentially reduce the quality of the drug.
You have 2 options:
Manufactured by Hetero Labs Limited.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.